These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 25701184

  • 41. Long-term sublingual immunotherapy provides better effects for patients with Japanese cedar pollinosis.
    Hamada S, Kobayashi Y, Sakamoto D, Shimamura A, Kuroda K, Kawachi R, Kanda A, Asako M, Gotoh M, Okubo K, Tomoda K, Iwai H.
    Auris Nasus Larynx; 2021 Aug; 48(4):646-652. PubMed ID: 33526319
    [Abstract] [Full Text] [Related]

  • 42. The Relationship of Pollen Dispersal with Allergy Symptoms and Immunotherapy: Allergen Immunotherapy Improves Symptoms in the Late Period of Japanese Cedar Pollen Dispersal.
    Sakurai T, Yonekura S, Iinuma T, Sakurai D, Morimoto Y, Kaneko S, Okamoto Y.
    Int Arch Allergy Immunol; 2018 Aug; 177(3):245-254. PubMed ID: 30021201
    [Abstract] [Full Text] [Related]

  • 43. Effect of Asian sand dust on Japanese cedar pollinosis.
    Ogi K, Takabayashi T, Sakashita M, Susuki D, Yamada T, Manabe Y, Fujieda S.
    Auris Nasus Larynx; 2014 Dec; 41(6):518-22. PubMed ID: 24928063
    [Abstract] [Full Text] [Related]

  • 44. Approaches to immunotherapies for Japanese cedar pollinosis.
    Sakaguchi M, Hirahara K, Fujimura T, Toda M.
    Auris Nasus Larynx; 2011 Aug; 38(4):431-8. PubMed ID: 21227607
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Inhibition of an Allergen-Antibody Reaction Related to Japanese Cedar Pollinosis Using DNA Aptamers Against the Cry j 2 Allergen.
    Ogihara K, Savory N, Abe K, Yoshida W, Arakawa M, Asahi M, Kamohara S, Ikebukuro K.
    Nucleic Acid Ther; 2015 Dec; 25(6):311-6. PubMed ID: 26484654
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY FOR JAPANESE CEDAR POLLINOSIS IN THE FIRST FOLLOW-UP YEAR].
    Yuta A, Ogawa Y, Suzuki Y, Arikata M, Kozaki H, Shimizu T, Ohta N.
    Arerugi; 2015 Dec; 64(10):1323-33. PubMed ID: 26727137
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Developmental history of sublingual immunotherapy].
    Du W, Maekawa Y, Natsui K.
    Nihon Yakurigaku Zasshi; 2019 Dec; 154(1):6-11. PubMed ID: 31308350
    [Abstract] [Full Text] [Related]

  • 54. DNA vaccination against Japanese cedar pollinosis in dogs suppresses type I hypersensitivity by controlling lesional mast cells.
    Masuda K.
    Vet Immunol Immunopathol; 2005 Oct 18; 108(1-2):185-7. PubMed ID: 16098609
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
    Pfaar O, Wolf H, Klimek L, Schnitker J, Wüstenberg E.
    Clin Ther; 2012 Oct 18; 34(10):2072-81. PubMed ID: 23063373
    [Abstract] [Full Text] [Related]

  • 60. Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost.
    Dranitsaris G, Ellis AK.
    J Eval Clin Pract; 2014 Jun 18; 20(3):225-38. PubMed ID: 24444390
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.